Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp Cigna Corp stake
total: 197
Muhlenkamp & Co CI trades
- Total transactions:
- 6
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2019 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2020 Q2
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any Cigna Corp (CI) shares. To date, the estimated cost basis is nearly $161.67 for "buy" trades and estimated average "sell" price is $204.37. Muhlenkamp & Co first purchased CI in 2015 Q1, initially acquiring 2,100 shares. Ronald Muhlenkamp later completely sold out the position and invested in Cigna Corp again in 2019 Q1. Since the initial investment in Cigna Corp (CI), Muhlenkamp & Co has made 5 more transactions.
When did Ronald Muhlenkamp sell Cigna Corp (CI)?
Ronald Muhlenkamp sold off the entire Cigna Corp (CI) position in 2020 Q2.
When did Ronald Muhlenkamp buy Cigna Corp (CI)?
Ronald Muhlenkamp first invested in Cigna Corp (CI) in 2015 Q1 at the reported quarter-end price of $129.52 per share.
What's the cost basis of Muhlenkamp & Co's CI stake?
The estimated cost basis for Cigna Corp (CI) stake is around $161.67 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $161.67
- Weighted AVG sell price:
- $204.37
Ronald Muhlenkamp's historical trades in Cigna Corp
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q2
|
0.00%
|
$204.49
|
-100% (-31,131)
|
|||
|
2019 Q4
|
2.78%
|
$204.49
|
+2.00% (+609)
|
|||
|
2019 Q2
|
2.34%
|
$157.56
|
-0.25% (-78)
|
|||
|
2019 Q1
|
2.33%
|
$160.82
|
new
|
|||
|
2015 Q2
|
0.00%
|
$129.52
|
-100% (-2,100)
|
|||
|
2015 Q1
|
0.06%
|
$129.52
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.